Magazine
ENEWS
SUBSCRIBE
WEBINARS
PODCASTS
EBOOKS
Edit submissions
Media kit
Innovation Awards
Home
Amgen’s Clinical Trial Setback With Colon Cancer Drug, Vectibix
March 23, 2007
Amgen's clinical trial of its cancer drug, Vectibix, has also found potential safety issues.
More on this
from
Business Week
.
pharmamanufacturing
Amgen's clinical trial of its cancer drug, Vectibix, has also found potential safety issues.
More on this
from
Business Week
.
About the Author
pharmamanufacturing | pharmamanufacturing
Latest from Home
Notable 2024 FDA decisions
Harnessing the power of bispecific antibodies
Virginia is for pharma lovers
Michael Annino/Shutterstock AI
Mining pharma's reshoring rush
Sponsored
Content
Special report: OT cybersecurity incident response — Are you ready?
Nevertheless, they persisted
Load More Content